Phase IV placebo-controlled study of atomoxetine hydrochloride [atomoxetine; Strattera] in the treatment of adults with ADHD [attention-deficit hyperactivity disorder] and comorbid social anxiety disorder
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2009
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder; Social phobia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 07 Jun 2007 Status change from in progress to completed.
- 14 Apr 2007 Status change from recruiting to in progress.
- 03 Dec 2005 New trial record.